Case Involving $21 Million Verdict May Determine Future Liability for Defective Generic Drugs
When most people go to the pharmacy to pick up a prescription from their doctor, they are usually happy to receive the generic version of the medication because it is much less expensive. This practice is so common that most states have laws that permit a pharmacist to substitute the generic version of a drug for the equivalent brand name when filling a prescription. Four in every five prescriptions are filled using a generic medication, but consumers may soon be asking for the brand name, depending on the Supreme Court’s ruling in a pending case, according to a Reuter’s report.
The case, Mutual Pharmaceutical Company v. Bartlett, U.S. Supreme Court, No. 12-142, will consider whether drug companies are liable for severe injuries and complications caused by the defective design of generic drugs. The case involves a drug company Mutual Pharmaceutical Company, a unit of URL Pharma, which is requesting the Supreme Court overturn a $21 million verdict awarded to Karen Bartlett for a severe incidence of Stevens-Johnson Syndrome. Bartlett suffered severe complications three weeks after taking the medications that caused her skin to peel away as well as severe lesions over much of her body. Bartlett was forced to spend two months in the burn unit of a hospital, including time in a medically induced coma. She also was forced to undergo thirteen eye surgeries. Her injuries left Bartlett nearly blind and suffering from difficulty swallowing and scarred lungs.
The pharmaceutical company is asking the Supreme Court to reverse an appellate court decision upholding the $21 million dollar verdict because federal law requires companies that manufacture generic drugs use the same design as the brand name drug. The pharmaceutical company is requesting that the Supreme Court extend its ruling in PLIVA v. Mensing that bars liability against makers of generic drugs based on a failure to warn of adverse side effects because generic drugs must carry the same label as the brand name equivalent.
The Boston appellate court upheld the jury verdict by distinguishing the Mensing case from Bartlett’s situation. The court reasoned that the drug company had the option of discontinuing sale of the generic version of the brand name drug Clinoril®. The ruling in this case could have a devastating impact on the ability of those who suffer life-altering adverse medical conditions and injuries to seek compensation against drug companies for injuries caused by generic drugs. Because our defective drug attorneys at Montlick and Associates are committed to holding drug companies accountable for injuries caused by their drugs, we hope the Supreme Court preserves the right to hold manufacturers of generic drugs liable for the defective design of their drugs. If the Supreme Court rules against Bartlett, future victims may be faced with the unpleasant choice of insisting on the higher priced brand name or forgoing the protection offered by imposing liability on the manufacturer of an unsafe generic drug.
Why Montlick & Associates?
Choosing the right law firm can make all the difference in getting you the best possible outcome. For over 35 years, the experienced Georgia Personal Injury Attorneys at Montlick & Associates have been helping families in Georgia and throughout the Southeast get the compensation and benefits they deserve after an accident. Montlick & Associates concentrates its practice on personal injury law, providing caring and high quality legal representation that helps injured people recover, not just financially, but physically and emotionally as well. In addition to its goal of being the best personal injury law firm in Georgia, Montlick & Associates is also dedicated to giving back to the community through the firm’s extensive public service programs.
The firm was recently honored by the Georgia House of Representatives for its 30 years of service with the passing of House Resolution 394 recognizing Montlick & Associates for "the outstanding accomplishments of this distinguished firm," and “for providing efficient, effective and dedicated services to the citizens of Georgia.” The firm was also named the Most Patriotic Business of 2011 by the Association of the United States Army in Atlanta for its efforts to support the troops, and its CEO David R. Montlick received a Patriotism Award in 2012 for the Southeast. To learn more about the firm’s award-winning public service programs, please visit Montlick.com/CommunityService.
The Georgia Defective Drug Attorneys at Montlick and Associates are available to provide effective legal representation to clients who suffer injuries throughout Georgia, including rural areas in the state and across the Southeast. No matter where you are located, the attorneys at Montlick & Associates are just a phone call away, and will even come to you. Call 24 hours a day/7 days a week for your Free Consultation at 1-800-LAW-NEED (1-800-529-6333). You can also visit online at www.montlick.com and use the firm’s Free 24-hour Live Online Chat or Free Case Evaluation Form.